Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The first nonabsorbable, gastrointestinal-selective antibiotic has been approved for the treatment of travelers’ diarrhea caused by noninvasive strains of <I>Escherichia coli</I>.

Pharmacology Update: Rifaximin Tablets (XifaxanTM)